Cytodyn Inc announced third quarter 2018 operating deficit of $-14.140507 millions
For the third quarter 2018 Cytodyn Inc increased losses of $-0.10 per share compare to $-0.06 a year ago and increased losses from $-0.07 per share from the previous quarter.
Sales remained unchanged to $0 millions from $0 millions in the same quarter a year ago and sequentially from $0 millions.
For the third quarter 2018 Cytodyn Inc realized net loss of $-18 million, bigger than $-8 million a year ago.
